CVE-2022-30982

CVE-2022-30982 is a medium-severity vulnerability in Gentics Gentics Cms with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

An issue was discovered in Gentics CMS before 5.43.1. There is stored XSS in the profile description and in the username.

Frequently asked questions

What is CVE-2022-30982?
An issue was discovered in Gentics CMS before 5.43.1. There is stored XSS in the profile description and in the username.
How severe is CVE-2022-30982?
CVE-2022-30982 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2022-30982 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-30982?
CVE-2022-30982 affects Gentics Gentics Cms. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-30982?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-30982 published?
CVE-2022-30982 was published on 2022-07-17 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Gentics Gentics Cms

All CVEs affecting Gentics Gentics Cms →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →